In Vivo looks at how gene therapies have gone from being just implausible science fiction premises, to becoming clinical realities taking an ever-larger portion of pharma R&D attention. This article covers how gene therapies work, where the field has been and where it’s going.
Author: Informa Pharma Intelligence
Published: 19 September 2019
Number of pages:11
Gene therapy is clearly taking medical science to the next level. See how it has taken the leap from treatment to cure and become one of the most exciting technologies in medicine. In Vivo looks at the history of gene therapy from mere fiction to actual cures reaching the market in enough numbers to drive large investment and deal making. See a full list of early triumphs by product, disease, country and originator and other key details, and learn how gene therapies work at the genome level either inside the body or outside before cells are reintroduced to the patient.
Datamonitor Healthcare is part of Pharma intelligence
Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726